|
|
|
Volumn 7, Issue 8, 2001, Pages 2309-2317
|
|
Temozolomide: The effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O6-alkylguanine-DNA-alkyltransferase
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 O ALKYLGUANINE DNA ALKYLTRANSFERASE;
DEOXYRIBONUCLEOPROTEIN;
TEMOZOLOMIDE;
TETRAZINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
ENZYME INACTIVATION;
FEMALE;
HUMAN;
HUMAN TISSUE;
MALE;
MONONUCLEAR CELL;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TISSUE LEVEL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, ALKYLATING;
AREA UNDER CURVE;
DACARBAZINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
MALE;
MIDDLE AGED;
NEOPLASMS;
NEUTROPENIA;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
THROMBOCYTOPENIA;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR CELLS, CULTURED;
|
|
EID: 0034886714
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (72)
|
|
References (27)
|
